Journal of Ayurveda and Integrated Medical Sciences (JAIMS)
Not a member yet
4014 research outputs found
Sort by
Standardization and Phytochemical Profiling of A.P. Har Tablet: An Ayurvedic Chewable Tablet for Hyperacidity
No full textHyperacidity and anorexia are common gastrointestinal disorders that significantly impact overall health and well-being. Hyperacidity is often associated with symptoms such as heartburn, bloating, and acid reflux, while anorexia results in reduced appetite and impaired digestion. A.P. Har Tablet is a chewable Ayurvedic formulation developed to effectively manage these conditions by combining traditional wisdom with modern convenience. It is based on Avipattikara Choornam, a classical formulation referenced in the Bhaishajya Ratnavali chapter 56, renowned for its efficacy in treating Amlapitta, Agnimandya, and Vibandha. To enhance palatability, patient compliance, and ease of administration, the traditional Choornam has been reformulated into a tablet form. This study focuses on the phytochemical analysis and standardization of A.P. Har Tablet to ensure consistent quality for its intended use in hyperacidity and anorexia. The formulation’s Pitta-pacifying, digestive, and appetizing properties make it a promising intervention in managing acid-related and appetite disorders. The findings aim to contribute to the scientific validation and quality assurance of Ayurvedic proprietary preparations in contemporary healthcare
Efficacy of Ayurvedic Management in Diabetes Mellitus Type II – A Case Study
No full textDiabetes mellitus is a metabolic disorder characterized by persistent hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and failure of various organs, and can cause Diabetic Retinopathy, Chronic Kidney Disease, Diabetic Neuropathy, and cardiovascular disorder. Out of 20 types of Prameha, Madhumeha is one type of Vataj Prameha which greatly resembling diabetes mellitus type 2. Additionally, Madhumeha also corrupts Oja (immunity). A 56-year-old Male, known case of Diabetes Mellitus Type 2 visited Jeena Sikho Lifecare Limited Hospital, Derabassi, Punjab, India, with complaints of uncontrolled Blood Glucose level with raised HbA1c level along with Vibandh (Constipation), Bahumutrata (Polyuria), Bala Kshaya (General weakness), Ajeerna (Indigestion), and Tanava (Stress). He was on Vildagliptin 50 mg with Metformin 500 mg once daily for 6 months. The symptoms and lab parameters however did not improved significantly. He was advised indoor treatment at Jeena Sikho Lifecare Limited Hospital, Derabassi, Punjab, India for Ayurvedic management for 9 days. Treatment protocol included Nidan Parivarjan (avoiding the causative factors), Dietary and lifestyle modifications, Shodhan Chikitsa by Panchkarma (removal of toxin from the body) and Shaman Chikitsa (controlling of aggravating Doshas in the body) by Ayurvedic Medicines consisting of ingredients like Triphala (Emblica officinalis, Terminalia bellirica, Terminalia chebula), Shilajit (Black Bitumen), Ashwagandha (Withania somnifera), Guduchi (Tinospora cordifolia), Neem (Azadirachta indica), Karela (Momordica charantia) etc. The patient followed all the treatments carefully, agreed to taper down the Allopathic tablets completely stopping in four days and kept on showing significant improvements in symptoms and lab parameters. Following the inpatient treatment, the doctor and patient remained in regular contact with proper follow-ups until May 31st, 2025. During this time, the patient consistently shared his blood glucose readings and HbA1c levels, which showed continuous improvement. This case study paves path for successful implementation of Ayurvedic regimen against DMT2, however for a disease as common as DM T2 a larger sample size will be more appropriate
Ayurveda’s Strategic Leap: Budget 2026 and the Birth of Three AIIA-Ayurveda Colleges
No full textThe Union Budget 2026 marks a pivotal moment for Ayurveda in India, announcing the establishment of three new AIIA-Ayurveda colleges under the aegis of the All India Institute of Ayurveda (AIIA). This initiative reflects the government’s commitment to mainstreaming traditional medicine within the national healthcare and education framework. Ayurveda, long recognized for its holistic approach to health and wellness, now stands at a crossroads—balancing ancient wisdom with modern institutional expansion. The creation of these colleges signifies more than infrastructural growth; it represents a strategic investment in capacity building, research, and global positioning of Ayurveda. Each institution is envisioned to serve as a hub for advanced clinical practice, interdisciplinary research, and standardized curriculum development aligned with NCISM guidelines. By integrating modern pedagogical methods, digital tools, and evidence-based research, these colleges aim to strengthen Ayurveda’s credibility and accessibility both nationally and internationally. The Budget 2026 allocation also underscores the importance of equitable healthcare delivery, with these colleges expected to enhance regional access to Ayurvedic education and services. Furthermore, the initiative is poised to generate employment opportunities, foster innovation in integrative medicine, and contribute to India’s health diplomacy by positioning Ayurveda as a global wellness brand. In conclusion, the birth of three AIIA-Ayurveda colleges under Budget 2026 represents a transformative step in institutionalizing Ayurveda. It highlights the government’s vision of blending tradition with modernity, ensuring that Ayurveda evolves as a robust, research-driven, and globally relevant system of medicine. This development situates Ayurveda at a critical juncture—where policy, education, and healthcare converge to shape its future trajectory
Ayurvedic management of Recurrent Chronic Urinary Tract Infection w.s.r. to Mutrakricha: A Case Study
No full textUrinary tract infection is the most common bacterial infection managed in general medicine practices, accounting for more than 3 percent. Commonly found in females than males, up to 50 percent of women have a UTI in their lifetime. In this case report, a female 56 years old patient presented with symptoms of burning micturition, increased frequency of urination with persistent urge to urinate, pain in the groin region, as well as turbid urine. Diagnosed with the case of recurrent UTI for 10 years, managed effectively with Chandraprabha Vati, Mutrvirechaneeya Kashya, and Basti Chikitsa. The assessment done before and after treatment showed significant changes in signs, symptoms, and the examination report. Follow-up visit showed no recurrence of UTI, changing the quality of life of the patient
Kutajarishta in Garbhaṇī Atisāra: Reviving Ancient Wisdom through Modern Evidence
No full textBackground: Garbhaṇī Atisāra, or diarrhea in pregnancy, poses risks of dehydration, electrolyte imbalance, and fetal compromise. Ayurvedic medicine recommends Kutajarishta, a fermented herbal formulation, for managing Atisāra. However, evidence on its efficacy and safety in pregnant women is limited.
Objective: To evaluate the therapeutic efficacy and safety of Kutajarishta in the management of Garbhaṇī Atisāra.
Methods: An open-label, controlled clinical study was conducted with 100 pregnant women (12–32 weeks gestation) diagnosed with mild to moderate diarrhea. Participants were divided into two groups: intervention (Kutajarishta 20 mL twice daily, n=50) and control (standard supportive care, n=50). Primary outcomes included reduction in stool frequency and improvement in stool consistency (Bristol Stool Scale) over 7 days. Secondary outcomes assessed relief of gastrointestinal symptoms and maternal-fetal safety parameters. Data were analyzed using Student’s t-test and Chi-square test, with p<0.05 considered significant.
Results: By Day 6, the Kutajarishta group showed a significant reduction in mean stool frequency (5.2 to 1.8/day) compared to controls (5.0 to 3.1/day; p<0.001) and improved stool consistency (Bristol score 6.1 to 3.5 vs 6.0 to 4.6; p<0.001). Gastrointestinal symptom scores, including abdominal cramps and urgency, improved faster in the intervention group. Maternal vital signs and fetal parameters (heart rate, movement count) remained stable in both groups. Only one mild adverse event (nausea) was reported in the intervention group.
Conclusion: Kutajarishta effectively reduces stool frequency, improves consistency, and alleviates gastrointestinal symptoms in pregnant women with Garbhaṇī Atisāra, without compromising maternal or fetal safety. Larger randomized trials are warranted to confirm these findings
Physiological Significance of Mamsa Dhatu: An Ayurvedic Insight with Modern Correlations
No full textBackground: Mamsa Dhatu, or muscular tissue, is the third of the seven Dhatus in Ayurveda and is essential to the body\u27s strength, protection, and structural support. Modern physiology clarifies its anatomical and functional parallels, whereas classical writings highlight its significance in health and illness. Objective: With an emphasis on its embryological genesis, characteristics, physiological functions, pathological alterations, and therapeutic significance, this paper examines Mamsa Dhatu from both Ayurvedic and contemporary viewpoints. Methods: With the help of reputable commentaries and contemporary biomedical literature, the study draws from Ayurvedic classics such as the Charaka Samhita, Sushruta Samhita, Ashtanga Hridaya, and Kashyapa Samhita. The digital repositories of AYUSH, Google Scholar, and PubMed were used to collect sources. Results: Prithvi and Jala Mahabhuta make up the majority of Mamsa Dhatu, which gives the body stability and unity. It adds to general strength and endurance while supporting ligaments, bones, and joints. In contemporary medicine, pathological alterations such Mamsa Kshaya (muscle wasting) and Mamsa Vriddhi (hypertrophy) correlate to diseases like myopathies, tumours, and metabolic disorders. Shodhana, Shamana, food, and exercise are examples of Ayurvedic therapies that closely resemble contemporary methods that incorporate physical training and nutrition. Conclusion: Our knowledge of muscle physiology, its problems, and treatment is enhanced when we examine Mamsa Dhatu from both an Ayurvedic and contemporary scientific perspective. There is potential for improving musculoskeletal research and clinical care with this integrative approach
Aja Dugdha: Bridging Ayurvedic Tradition and Modern Nutrition
No full textAja Dugdha (goat milk) is a highly valued dietary substance in Ayurveda, described as Pathya (wholesome) for various conditions, particularly in Rajayakshma (tuberculosis), Kshaya (emaciation), Jwara (fever), and pediatric disorders. It is known for its Laghu (light), Madhura (sweet) and Sheeta (cooling) qualities, which make it easy to digest and nourishing. Modern studies reveal its rich nutrient profile, hypoallergenic properties, and beneficial bioactive components, making it a valuable alternative to cow milk in lactose intolerance and certain allergic conditions. This review explores the Ayurvedic references, pharmacological properties, clinical applications, and recent scientific findings on goat milk
Restoring Steps: A Rare Case Report on Ayurveda Intervention in Congenital Posteromedial Bowing of Tibia [CPMBT]
No full textAyurveda, as a holistic science of life, encompasses not only the treatment of diseases but also the promotion of overall health and well-being. It describes numerous diseases and classifies them into different categories based on their symptoms and origin. In this context, Adibala Pravritta and Janmabala Pravritta are grouped under Garbhajanya Vikriti (congenital disorders). These conditions primarily arise due to maternal or paternal factors, as well as defects in the progeny itself. Additionally, improper diet and lifestyle practices followed by the mother are also considered significant contributors to congenital birth defects. Congenital Posteromedial Bowing of tibia [CPMBT] is a Rare condition with very limited incidence caused due to result of intrauterine positioning that typically presents with a Calcaneovalgus foot deformity and leg length discrepancy. A 8 days old Single Live Term/Male Baby was brought to the Kaumarabhritya OPD with complaints of Posteromedial Bowing of tibia associated with dorsiflexion of foot. Baby was admitted and treated using Vatahara and Brimhana therapies, including Pichu Bandhana, Abhyanga, and Matra Basti. Now, at 3½ months of age, significant improvement in the structural alignment, bowing, leg length disparity and range of movements has been observed
Panchgavya and its effect on Human and Environmental Health: An Ayurvedic Perspective
No full textPanchgavya is a traditional Ayurvedic formulation made from five cow-derived products—milk, curd, ghee, urine, and dung. This formulation is believed to balance the three Dosha (Vata, Pitta, and Kapha), enhancing physical, mental, and spiritual well-being. Beyond its health benefits, Panchgavya supports sustainable agriculture and environmental health. This abstract examines its molecular composition and its dual role in promoting human health and ecological balance through Ayurvedic principles. Panchgavya offers a holistic approach to enhancing human and environmental health. Its components support immune function, gut health, and sustainable agricultural practices, bridging ancient Ayurvedic wisdom with modern ecological needs
Ayurvedic Management of Vatarakta - A Case Study
No full textVatarakta, is a chronic inflammatory disease, poses significant challenges in conventional treatment approaches, symptomatic management. This study aimed to investigate the efficacy of Manjistadi Niruha Basti, a traditional Ayurvedic treatment, in curing Vatarakta. A 22 year old male patient with Chronic Vatarakta was administered Manjistadi Niruha Basti. The treatment involved daily enemas with Manjista and other herbs. The patient’s symptoms and quality was assessed before, during and after treatment. Improvement noticed that is reduction in pain, stiffness, Oedema after Basti. The results of this study suggest that Manjistadi Niruha Basti is a potentially effective treatment for Vatarakta, addressing the pathophysiology and promoting holistic healing. The significant improvement in symptoms and quality of life indicate treatment efficacy in managing this chronic inflammatory disease. Further studies are warranted to confirm these findings and establish Manjistadi Niruha Basti as a viable treatment option of Vatarakta